Rappler's latest stories on coronavirus treatment
Monkeys develop virus immunity after infection, vaccine – studies
The authors of the study cautions that further research will be needed because of the 'important differences' between SARS-CoV-2 infection in monkeys and humans
Scientists in China believe new drug can stop pandemic 'without vaccine'
A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say
Japan approves remdesivir for coronavirus treatment
This makes Japan the second country to approve the drug after US regulators authorized it for emergency use against severe cases of COVID-19
'Don't waste a minute': Chinese firm readies mass vaccine production
While human trials have just started, the company says it is ready to make 100 million doses per year to combat the virus
Hopes rise in coronavirus battle as U.S. scientists hail drug trial
Anthony Fauci, who oversaw the study, tells reporters at the White House: 'The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery'
U.S. gov't reveals details of sunlight study on coronavirus
The amount of virus suspended in air shrunk to half its amount in just 1.5 minutes at room temperature and 20% humidity, says DHS official William Bryan
Closely watched arthritis drug disappoints in coronavirus trial
There is, however, a ray of hope for those who are 'critical'
What is chloroquine and could it cure the coronavirus?
Nonetheless, experts urge caution until bigger trials validate their effectiveness
Pharma chiefs expect coronavirus vaccine in 12-18 months
'We're confident technology will arrest this disease,' says IFPMA president David Ricks
U.S. fast-tracking antimalarials to treat coronavirus
'If there is an experimental drug that is potentially available, a doctor could ask for that drug to be used in a patient," says FDA Commissioner Stephen Hahn